Healthcare, biotechnology & medical AI Product
ThinkSono Guidance assists with acquiring vascular ultrasound images
ThinkSono Guidance provides live image-acquisition guidance for a specified lower-limb vascular ultrasound workflow related to suspected deep vein thrombosis. [1]
- Release status
- U.S. FDA 510(k) clearance K260338, decided July 15, 2026. [1]
What it does
The FDA cleared ThinkSono Guidance under K260338 on July 15, 2026, as Class II AI-guided image acquisition software. [1]
Why it matters
The decision defines the software’s role at the image-acquisition stage. It distinguishes guidance while collecting images from interpreting the resulting examination. [1]
Who it’s for
The labeling describes healthcare professionals without prior ultrasound training as operators and qualified clinicians as image reviewers. [1]
Key dates
- FDA clears ThinkSono Guidance [1]
Where it fits
The software is an accessory to compatible handheld point-of-care ultrasound systems and supports acquisition for later professional interpretation. [1]
Limits and trade-offs
The clearance is limited to the acquisition role and the indicated vascular imaging workflow. Clinical interpretation remains a separate task. [1]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision K260338: ThinkSono Guidance
- Primary source ThinkSono newsroom
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
Methinks Stroke suite
Methinks AI
Provides radiology triage and notification software, with separate FDA decisions for Methinks NCCT Stroke and CTA Stroke.